Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.23239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients

Oncotarget
Oncology
2017English

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

Downregulation of microRNA‑374a Predicts Poor Prognosis in Human Glioma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Elevated Serum Visfatin Levels Are Associated With Poor Prognosis of Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy